IREN, once known for Bitcoin mining, uses the Mirantis deal to shift from selling raw computing power to offering a fuller AI cloud service that big companies can run on. That creates a bigger long-term opportunity, but it hinges on smooth integration and actually winning enterprise customers in a crowded market.Read more

Below is a sell-side / investment banking style investment memo on Village Farms International (NASDAQ: VFF), fully based on the Q1 2026 results and FY2025 10-K annual report you provided, with verified data points and citations. Village Farms International (VFF) – Investment Memo Date: May 2026 Executive Summary Village Farms International (“Village Farms” or the “Company”) is a vertically integrated, low-cost cannabis producer with a differentiated heritage in Controlled Environment Agriculture (CEA).Read more

Everpure starts to look less like a plain data-storage seller and more like a key piece of the gear big cloud and AI teams rely on to keep expensive chips busy. If that shift sticks, the market may start treating it like an AI infrastructure company—but the upside depends on a few large customers and still-unproven new products.Read more

Below is a fact-checked, integrated investment memo on Paradigm Biopharmaceuticals (ASX: PAR), made with copilot help, (if you find any errors, please let me know); combining validation of AmirV claims with external sources and a professional investment framework. Investment Memo: Paradigm Biopharmaceuticals (ASX: PAR) Ticker: PAR (ASX) Sector: Biotechnology (Late-stage clinical) Core Asset: Zilosul® (injectable pentosan polysulfate sodium, PPS) Date: May 2026 1.Read more

One of China’s biggest made-to-order tea chains spreads fastest in smaller cities, using franchised shops and its own delivery network to keep quality consistent. That mix helps it grow quickly, but fierce price battles and uneven franchise execution could test the brand as the market crowds up.Read more

A small kidney-disease drug developer is nearing a make-or-break decision that could turn it from a research story into a company with real product sales. The big question is whether it can clear past manufacturing hurdles and win over dialysis clinics that are slow to change and tightly controlled by insurers.Read more

Investment Memo – Roche Holding AG (Pharmaceutical Division / “Roche Pharma”) 1. Executive Summary Roche is a leading global pharmaceutical and diagnostics company with a strong focus on oncology, immunology, neuroscience, and rare diseases.Read more

Investment Memorandum – CATL Executive Summary CATL is the global leader in lithium-ion battery manufacturing , supplying electric vehicle (EV) and energy storage batteries to major OEMs worldwide. The company has established a dominant position across both power batteries (~EV) and energy storage systems , supported by scale, vertical integration, and continuous innovation.Read more

Below is a sell‑side / investment banking–style Investment Memorandum (IM) on International Business Machines Corporation (IBM) , structured as it would appear in a professional transaction or equity capital markets context. Investment Memorandum International Business Machines Corporation (NYSE: IBM) 1.Read more